Attached files
| file | filename |
|---|---|
| 10-K - QUANTRX BIOMEDICAL CORP | v179442_10k.htm |
| EX-99.2 - QUANTRX BIOMEDICAL CORP | v179442_ex99-2.htm |
| EX-31.1 - QUANTRX BIOMEDICAL CORP | v179442_ex31-1.htm |
| EX-31.2 - QUANTRX BIOMEDICAL CORP | v179442_ex31-2.htm |
| EX-23.1 - QUANTRX BIOMEDICAL CORP | v179442_ex23-1.htm |
| EX-32.1 - QUANTRX BIOMEDICAL CORP | v179442_ex32-1.htm |
| EX-99.1 - QUANTRX BIOMEDICAL CORP | v179442_ex99-1.htm |
EXHIBIT
32.2
CERTIFICATION
PURSUANT
TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of QuantRx Biomedical Corporation (the
"Company") on Form 10-K for the year ending December 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Sasha
Afanassiev, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to my knowledge:
1. The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
|
Sasha
Afanassiev
|
|
Date: March
31, 2010
A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.